Cargando…

The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles

Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry....

Descripción completa

Detalles Bibliográficos
Autores principales: Docter, Dominic, Bantz, Christoph, Westmeier, Dana, Galla, Hajo J, Wang, Qiangbin, Kirkpatrick, James C, Nielsen, Peter, Maskos, Michael, Stauber, Roland H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168937/
https://www.ncbi.nlm.nih.gov/pubmed/25247121
http://dx.doi.org/10.3762/bjnano.5.151
_version_ 1782335645002235904
author Docter, Dominic
Bantz, Christoph
Westmeier, Dana
Galla, Hajo J
Wang, Qiangbin
Kirkpatrick, James C
Nielsen, Peter
Maskos, Michael
Stauber, Roland H
author_facet Docter, Dominic
Bantz, Christoph
Westmeier, Dana
Galla, Hajo J
Wang, Qiangbin
Kirkpatrick, James C
Nielsen, Peter
Maskos, Michael
Stauber, Roland H
author_sort Docter, Dominic
collection PubMed
description Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry. Here, the physico-chemical characteristics of NP are widely discussed as critical determinants, albeit the exact mechanisms remain to be resolved. Moreover, proteins associate with NP in physiological fluids, forming the protein corona potentially transforming the biological identity of the particle and thus, adding an additional level of complexity for the bio–nano responses. Here, we employed amorphous silica nanoparticles (ASP) and epithelial GI tract Caco-2 cells as a model to study the biological impact of particle size as well as of the protein corona. Caco-2 or mucus-producing HT-29 cells were exposed to thoroughly characterized, negatively charged ASP of different size in the absence or presence of proteins. Comprehensive experimental approaches, such as quantifying cellular metabolic activity, microscopic observation of cell morphology, and high-throughput cell analysis revealed a dose- and time-dependent toxicity primarily upon exposure with ASP30 (Ø = 30 nm). Albeit smaller (ASP20, Ø = 20 nm) or larger particles (ASP100; Ø = 100 nm) showed a similar zeta potential, they both displayed only low toxicity. Importantly, the adverse effects triggered by ASP30/ASP30L were significantly ameliorated upon formation of the protein corona, which we found was efficiently established on all ASP studied. As a potential explanation, corona formation reduced ASP30 cellular uptake, which was however not significantly affected by ASP surface charge in our model. Collectively, our study uncovers an impact of ASP size as well as of the protein corona on cellular toxicity, which might be relevant for processes at the nano–bio interface in general.
format Online
Article
Text
id pubmed-4168937
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-41689372014-09-22 The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles Docter, Dominic Bantz, Christoph Westmeier, Dana Galla, Hajo J Wang, Qiangbin Kirkpatrick, James C Nielsen, Peter Maskos, Michael Stauber, Roland H Beilstein J Nanotechnol Full Research Paper Besides the lung and skin, the gastrointestinal (GI) tract is one of the main targets for accidental exposure or biomedical applications of nanoparticles (NP). Biological responses to NP, including nanotoxicology, are caused by the interaction of the NP with cellular membranes and/or cellular entry. Here, the physico-chemical characteristics of NP are widely discussed as critical determinants, albeit the exact mechanisms remain to be resolved. Moreover, proteins associate with NP in physiological fluids, forming the protein corona potentially transforming the biological identity of the particle and thus, adding an additional level of complexity for the bio–nano responses. Here, we employed amorphous silica nanoparticles (ASP) and epithelial GI tract Caco-2 cells as a model to study the biological impact of particle size as well as of the protein corona. Caco-2 or mucus-producing HT-29 cells were exposed to thoroughly characterized, negatively charged ASP of different size in the absence or presence of proteins. Comprehensive experimental approaches, such as quantifying cellular metabolic activity, microscopic observation of cell morphology, and high-throughput cell analysis revealed a dose- and time-dependent toxicity primarily upon exposure with ASP30 (Ø = 30 nm). Albeit smaller (ASP20, Ø = 20 nm) or larger particles (ASP100; Ø = 100 nm) showed a similar zeta potential, they both displayed only low toxicity. Importantly, the adverse effects triggered by ASP30/ASP30L were significantly ameliorated upon formation of the protein corona, which we found was efficiently established on all ASP studied. As a potential explanation, corona formation reduced ASP30 cellular uptake, which was however not significantly affected by ASP surface charge in our model. Collectively, our study uncovers an impact of ASP size as well as of the protein corona on cellular toxicity, which might be relevant for processes at the nano–bio interface in general. Beilstein-Institut 2014-08-27 /pmc/articles/PMC4168937/ /pubmed/25247121 http://dx.doi.org/10.3762/bjnano.5.151 Text en Copyright © 2014, Docter et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjnano/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Nanotechnology terms and conditions: (https://www.beilstein-journals.org/bjnano/terms)
spellingShingle Full Research Paper
Docter, Dominic
Bantz, Christoph
Westmeier, Dana
Galla, Hajo J
Wang, Qiangbin
Kirkpatrick, James C
Nielsen, Peter
Maskos, Michael
Stauber, Roland H
The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
title The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
title_full The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
title_fullStr The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
title_full_unstemmed The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
title_short The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
title_sort protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles
topic Full Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168937/
https://www.ncbi.nlm.nih.gov/pubmed/25247121
http://dx.doi.org/10.3762/bjnano.5.151
work_keys_str_mv AT docterdominic theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT bantzchristoph theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT westmeierdana theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT gallahajoj theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT wangqiangbin theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT kirkpatrickjamesc theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT nielsenpeter theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT maskosmichael theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT stauberrolandh theproteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT docterdominic proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT bantzchristoph proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT westmeierdana proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT gallahajoj proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT wangqiangbin proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT kirkpatrickjamesc proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT nielsenpeter proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT maskosmichael proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles
AT stauberrolandh proteincoronaprotectsagainstsizeanddosedependenttoxicityofamorphoussilicananoparticles